PLAY PODCASTS
COVID-19: Answering the Questions, Part 16
Episode 37

COVID-19: Answering the Questions, Part 16

In Part 16 of this ongoing series, listen to an update on immunity to emerging COVID-19 variants from Sharon R. Lewin, AO, FRACP, PhD, FAHMS, followed by her answers to COVID-19 questions.

Decera Clinical Education Infectious Disease Podcast · Sharon R. Lewin AO FRACP PhD FAHMS

February 12, 202137m 38sExplicit

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19. 

Presenter:

Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor of Infectious Diseases 
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

mrna vaccinesars-cov-2 preventioncovid-19 incidenceuk variantjohnson & johnson vaccinebamlanivimabsevere covid-19emerging variantssars-cov-2 incidencemoderna vaccinecovid-19 mortalitycovid-19 monoclonal antibody treatmentsars-cov-2 transmissioncovid-19 treatmentcovid-19 endemiccovid-19 eliminationsouth africa variantpfizer vaccinenovovax vaccinecovid-19 variantscovid-19 vaccinecovid-19sars-cov-2 mutationscovid-19 strainscovid-19 antibodiescovid-19 hospitalizationsb117 variantcovid-19 mutationscovid-19 preventionsars-cov-2covid-19 public health